Dietary phenylalanine requirements during early and late gestation in healthy pregnant women

Abstract

ABSTRACT Background Phenylalanine is an indispensable amino acid and, via tyrosine, is the precursor for the neurotransmitters dopamine, norepinephrine, and epinephrine. Currently, dietary requirements for phenylalanine during pregnancy are unknown. Objectives This study's aim was to determine phenylalanine requirements (in the presence of excess tyrosine) during early and late gestation using direct amino acid oxidation (DAAO; with l-[1-13C]phenylalanine) and indicator amino acid oxidation (IAAO; with l-[1-13C]leucine). Methods Twenty-three healthy women (age: 30.4 ± 3.1 y, mean ± SD) were studied at a range of phenylalanine intakes (5.5–30.5 mg · kg−1 · d−1 in early and late pregnancy using DAAO, and 2.5–30.5 mg · kg−1 · d−1 in late pregnancy using IAAO) for a total of 76 study days. Test intakes were provided as 8 isocaloric and isonitrogenous meals with 1.5 g · kg−1 · d−1 protein and energy at 1.7 times the measured resting energy expenditure. Breath samples were analyzed on an isotope ratio mass spectrometer for 13C enrichment. Phenylalanine requirement was determined using a 2-phase linear regression crossover model to identify a breakpoint in 13CO2 production (representing the mean requirement) in response to phenylalanine intakes. Results Phenylalanine requirement during early pregnancy was determined to be 15 mg · kg−1 · d−1 (95% CI: 10.4, 19.9 mg · kg−1 · d−1); during late pregnancy, it was determined to be 21 mg · kg−1 · d−1 by DAAO (95% CI: 17.4, 24.7 mg · kg−1 · d−1) and IAAO (95% CI: 10.5, 32.2 mg · kg−1 · d−1). Conclusions Our results suggest a higher requirement (40%) for phenylalanine during late pregnancy than during early pregnancy. Moreover, the early pregnancy requirements are higher than the previous adult male requirement (9.1 mg · kg−1 · d−1; 95% CI: 4.6, 13.6 mg · kg−1 · d−1), although the 95% CIs overlap. Both DAAO and IAAO methods provided similar breakpoints in late pregnancy, showing that the DAAO method was appropriate even though low phenylalanine intakes could not be tested. These results have potential implications for gestation stage–specific dietary phenylalanine recommendations in future. This trial was registered at clinicaltrials.gov as NCT02669381.